As the dominance of Covid-19 on the public health agenda subsides, it’s time to reflect anew on the significant issue of antimicrobial resistance (AMR) – a public health and environmental challenge that has been growing in prominence in recent years, and which shows no signs of slowing down.

AMR develops when microbes evolve so that they do not respond to antimicrobial substances, such as antibiotics. This process can happen for a number of reasons, including exposure of microbial organisms to antimicrobial chemicals.

The World Health Organization (WHO) has declared AMR “one of the top ten global public health threats facing humanity”. And rightly so – it increases the development of drug-resistant pathogens – or superbugs – which have the potential to jeopardise modern medicine, making infections harder to treat, and significantly increasing the risks associated with common medical procedures/treatment, such as surgery and chemotherapy.

While public health campaigns have raised awareness of the need to reduce unnecessary antibiotic use in humans, it remains a problem across the world; and antibiotic usage is also widespread in farming and aquaculture.

Another potential contributor to AMR is the use of everyday biocide products (e.g. Short et al., 2021) – including surface disinfectants and hand sanitisers. Such substances, although necessary in certain settings and situations, require responsible use. The use of biocides increased dramatically during Covid-19, and there are some indications that this has enhanced the prevalence of environmental AMR (e.g. Mahoney et al., 2021; Mohapatra et al., 2023; Hu et al., 2023).

The environment can be a key reservoir for AMR. Routes of AMR from the environment to humans include sewage (e.g. Nguyen et al., 2021; Samreen et al., 2021; Larsson et al., 2023). Although further work is ongoing in this area, research has indicated that users of natural coastal recreational waters can be exposed to AMR via this route (e.g. Leonard et al., 2015; Farrell, M.L. et al., 2021). The UK government has acknowledged the severity of the AMR risk for our society, and has put together a key 20-year vision and 5-year plan to tackle AMR, which includes a particular focus on minimising the spread of AMR through the environment. 

The Atkins water quality team has been working with clients to explore the presence of environmental AMR, and we have developed strong expertise in this important specialist field, working with world-leading scientists in the sector.

We have undertaken Evidence Reviews for the Department for the Environment, Food & Rural Affairs reviewing latest knowledge and understanding on aspects of AMR. We have also worked with the Environment Agency, and in collaboration with UKCEH, on bringing together a wide range of datasets relating to AMR into an easy-to-use geodatabase; as well as selecting pilot sites for an AMR surveillance programme, which will provide valuable information on the presence of environmental AMR. This work recently featured in the Chief Scientist’s Annual Review report about key issues affecting the environment.

There is plenty we can do to alleviate the severity of AMR going into the future, but we need to begin to acknowledge it as an urgent issue and increase awareness and education. Dame Sally Davies (previous Chief Medical Officer for England) said that ‘Antibiotic resistance could kill us before the climate crisis does’, yet public perception of AMR is not even close to being on a par with other issues, where we have seen considerable changes in attitudes and behaviours over the past decade.

As the WHO continues to push for the prioritisation of AMR across the global community, we all need to move AMR up the agenda - raising awareness and changing behaviours at all levels in all nations to tackle a challenge together that affects us all.


References

Farrell et al., 2021. Evaluating the potential for exposure to organisms of public health concern in naturally occurring bathing waters in Europe: A scoping review. Water Research, 206, 117711.

Hu et al., 2023. Excessive disinfection aggravated the environmental prevalence of antimicrobial resistance during COVID-19 pandemic. Science of the Total Environment, 882, 163598.

Larsson et al., 2023.Sewage surveillance of antibiotic resistance holds both opportunities and challenges. Nature Reviews Microbiology, 21: 213-214.

Leonard et al., 2015. Human recreational exposure to antibiotic resistant bacteria in coastal bathing waters. Environment International Volume 82: 92-100.

Mahoney et al., 2021. The silent pandemic: Emergent antibiotic resistances following the global response to SARS-CoV-2. iScience, 24: 102304

Mohapatra et al., 2023. Quaternary ammonium compounds of emerging concern: Classification, occurrence, fate, toxicity and antimicrobial resistance. Journal of Hazardous Materials, 445: 130393

Nguyen et al., 2021. Monitoring antibiotic resistance genes in wastewater treatment: Current strategies and future challenges. Science of the Total Environment, 783:146964.

Samreen et al., 2021. Environmental antimicrobial resistance and its drivers: a potential threat to public health. Journal of Global Antimicrobial Resistance 27: 101-111.

Short, F.L. et al., 2021. Benzalkonium chloride antagonises aminoglycoside antibiotics and promotes evolution of resistance. EBioMedicine, 73: 103653.

DISCLAIMER

Please note that you are now leaving the AtkinsRéalis website (legal name: AtkinsRéalis Group inc.) and entering a website maintained by a third party (the "External Website") and that you do so at your own risk.

AtkinsRéalis has no control over the External Website, any data or other content contained therein or any additional linked websites. The link to the External Website is provided for convenience purposes only. By clicking "Accept" you acknowledge and agree that AtkinsRéalis is not responsible, and does not accept or assume any responsibility or liability whatsoever for the data protection policy, the content, the data or the technical operation of the External Website and/or any linked websites and that AtkinsRéalis is not liable for the terms and conditions (or terms of use) of the External Website. Further, you acknowledge and agree that you assume all risks resulting from entering and/or using the External Website and/or any linked websites.

BY ENTERING THE EXTERNAL WEBSITE, YOU ALSO ACKNOWLEDGE AND AGREE THAT YOU COMPLETELY AND IRREVOCABLY WAIVE ANY AND ALL RIGHTS AND CLAIMS AGAINST ATKINSRÉALIS, AND RELEASE, DISCHARGE, INDEMNIFY AND HOLD HARMLESS ATKINSRÉALIS, ITS OFFICERS, EMPLOYEES, DIRECTORS AND AGENTS FROM ANY AND ALL LIABILITY INCLUDING BUT NOT LIMITED TO LIABILITY FOR LOSS, DAMAGES, EXPENSES AND COSTS ARISING OUT OF OR IN CONNECTION WITH ENTERING AND/OR USING THE EXTERNAL WEBSITE AND/OR ANY LINKED WEBSITES AND ANY DATA AND/OR CONTENT CONTAINED THEREIN.

Such waiver and release specifically includes, without limitation, any and all rights and claims pertaining to reliance on the data or content of the External Website, or claims pertaining to the processing of personal data, including but not limited to any rights under any applicable data protection statute. You also recognize by clicking “Accept” that the terms of this disclaimer are reasonable.

The information provided by Virtua Research cited herein is provided “as is” and “as available” without warranty of any kind. Use of any Virtua Research data is at a user’s own risk and Virtua Research disclaims any liability for use of the Virtua Research data. Although the information is obtained or compiled from reliable sources Virtua Research neither can nor does guarantee or make any representation or warranty, either express or implied, as to the accuracy, validity, sequence, timeliness, completeness or continued availability of any information or data, including third-party content, made available herein. In no event shall Virtua Research be liable for any decision made or action or inaction taken in reliance on any information or data, including third-party content. Virtua Research further explicitly disclaims, to the fullest extent permitted by applicable law, any warranty of any kind, whether express or implied, including warranties of merchantability, fitness for a particular purpose and non-infringement.

The consensus estimate provided by Virtua Research is based on estimates, forecasts and predictions made by third party financial analysts, as described above. It is not prepared based on information provided by AtkinsRéalis and can only be seen as a consensus view on AtkinsRéalis' possible future results from an outside perspective. AtkinsRéalis has not provided input on these forecasts, except by referring to past publicly disclosed information. AtkinsRéalis does not accept any responsibility for the quality or accuracy of any individual or average of forecasts or estimates. This web page contains forward-looking statements based on current assumptions and forecasts made by third parties. Various known and unknown risks, uncertainties and other factors could lead to material differences between AtkinsRéalis' actual future results, financial situation, development or performance, and the estimates given here.



Downloads

Trade releases